Dr. Puja Kathrotiya Konda, MD

Dr. Konda practices at Midstate Skin Institute in Ocala, Florida.

Dr. Konda's NPI, 1770837189, was assigned on November 7, 2012. Dr. Konda graduated from Indiana University School Of Medicine in 2012. Dr. Konda holds Florida license ME124603.

Dr. Konda's primary practice is Midstate Skin Institute, at 1740 Se 18th St, Ocala, FL 34471 in Marion County. The practice phone is (352) 512-0092.

Dr. Konda's primary practice is Midstate Skin Institute in Ocala, Florida. The medical group on file is MidState Skin Institute. Dmand AI also links Dr. Konda to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Konda practices. Vendor and product names are available with a free account.

Dermatology is Dr. Konda's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Konda is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Konda's licenses on file in 2 states: Florida and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, corns and calluses and facial skin infection among the conditions Dr. Konda treats.

CMS data shows 12,553 Medicare services from Dr. Konda across 31 procedure codes in 2024, for 2,400 Medicare patients. Medicare paid $550,570 for them. Every service was in an office.

CMS counts 2,400 Medicare patients who saw Dr. Konda in 2024. The largest group is 65 to 74, with 1,154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Konda's median patient age at 74, with 60% women.

In 2024, Dr. Konda wrote 1,902 Medicare Part D claims for 727 patients. 91% of them were for generic drugs. CMS names the drug for 1,686 of them, across 24 drugs with 11 or more claims each, at $660,935 in total drug cost. In 2023, CMS named 1,530 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Konda for performance year 2024, reported as part of a group. Dr. Konda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 3,540 procedures of removal of skin lesions by Dr. Konda, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 581 general payments to Dr. Konda from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 95% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,363.

Dr. Konda graduated from Indiana University School Of Medicine in 2012.

Dr. Konda is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 12. Check the plan with the practice before a visit.